Panacea closes second healthcare fund on $276m
Panacea Venture, a healthcare-focused investment firm established by James Huang, formerly a partner at KPCB China, has closed its second fund with approximately USD 276m in commitments.
The corpus comprises two vehicles, Panacea Venture Healthcare Fund II and Panacea Opportunity Fund I. A statement issued by the firm’s placement agent, Atlantic-Pacific Capital, did not specify the size...
More on Greater China
Latest News
Monolith sets $250m hard cap for China fund
Monolith Management, an investment firm established by Xi Cao, formerly a partner at Sequoia Capital China, has set the hard cap at USD 250m for its debut China venture capital fund.
Adamantem buys Australia's Retail Zoo from Bain
Adamantem Capital has acquired a majority stake in Retail Zoo, operator of Australia-headquartered food retail brands Boost Juice and Betty’s Burgers, from Bain Capital for an undisclosed sum.
Carlyle names Harvey Schwartz as CEO
The Carlyle Group has appointed Harvey M. Schwartz, formerly president and co-COO of Goldman Sachs, as its new CEO.
AVCJ Awards 2022: Deal of the Year – Large Cap: Crown Resorts
Crown Resorts represented a daunting target, given its size and pandemic and regulatory-related challenges. The Blackstone Group drew on its global know-how to make the USD 8.1bn deal work